Skip to main content

Table 1 Viral serological markers follow up of hepatitis B reactivation patient

From: Reactivation of occult hepatitis B virus infection in a renal transplant recipient

Assay/Month

Pre-trans

Post-trans

Date

Nov 2019

Dec 20201*

Dec 20202*

Feb 2021

Mar 2021

May 2021

Jul 2021

Aug 2021

Dec 2021

Mar 2022

May 2022

HBV-DNA(IU/ml)

ND*

68.6

74.5

2440

Neg

Neg

Neg

Neg

Neg

Neg

Neg

HBsAg(mIU/ml)

Neg

Neg

Neg

Neg

Neg

Neg

Neg

Neg

Neg

Neg

Neg

HBsAb(mIU/mL)

146.91

249.75

270.5

456.95

799.21

951.36

653.66

508.48

288.08

197.98

170.27

HBeAg(PEIU/ml)

0.16

0.15

0.19

1.02

0.08

0.08

0.08

0.08

0.06

0.06

0.06

HBeAb(s/co)

Neg

Neg

Neg

Neg

Neg

Pos

Pos

Pos

Pos

Neg

Pos

HBcAb(s/co)

Pos

Pos

Pos

Pos

Pos

Pos

Pos

Pos

Pos

Pos

Pos

  1. Dynamic monitoring of serological parameters of HBV infection after renal transplantation. Serological HBV parameters (HBsAg, HBcAb, HBsAb, HBeAg, and HBeAb) were analysed (using kits from Abbott Laboratories) between November 2019 and May 2022. HBV viral load was determined by TaqMan PCR assay (Shanghai Zhijiang Biology) and is expressed in IU/ml (threshold level = 30 IU/ml)
  2. ND* not detected; Neg negative in a semi-quantitative assay or HBV viral load below the detection limit
  3. Dec 20201* and Dec 20202*: there were two different testing times in December 2020. In early December 2020, the patient was negative for serum HBsAg but positive for HBV-DNA. Two weeks later, blood was collected again for retesting